Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristopher J Swiger

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Heart Association|April 24, 2014
Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B)Kristopher J Swiger, Seth S Martin, Michael J Blaha, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Clinical Cardiology|October 15, 2013
Very large database of lipids: rationale and designSeth S Martin, Michael J Blaha, Peter P Toth, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of the American Heart Association|April 24, 2014
Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B)Kristopher J Swiger, Seth S Martin, Michael J Blaha, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Clinical Cardiology|October 15, 2013
Very large database of lipids: rationale and designSeth S Martin, Michael J Blaha, Peter P Toth, et al.
Pageof 2